Nadia Rosenthal;Daniel Bilbao Cortes;Luisa Luciani
发明人:
Daniel Bilbao Cortes,Nadia Rosenthal,Luisa Luciani
申请号：
US14350305
公开号：
US20140286906A1
申请日:
2012.10.05
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to the use of the Insulin-like growth factor-I (IGF-1) in immune modulation and/or in the treatment or prevention of pathogenic or aberrant immune responses or disorders and/or for use in the treatment or prevention of T-cell mediated disorders or diseases and/or for use in the treatment or prevention of diseases where the immune system contributes to the disease state.
